Dysthymia Article
Dysthymia characteristics include an extended period of depressed mood combined with a minimum of two other symptoms which can include
insomnia or hypersomnia, fatigue or low energy, eating changes (more or less), low self-esteem, or feelings of hopelessness. Poor concentration or difficulty making decisions are treated as another possible symptom. Mild degrees of dysthymia may end in people withdrawing from
stress and avoiding opportunities for failure. In more severe cases of dysthymia, people may even withdraw from daily activities. They will usually find little pleasure in usual activities and pastimes. Diagnosis of dysthymia is often difficult due to the subtle nature of the symptoms and patients can often hide them in social situations, making it challenging for others to detect symptoms. Additionally, dysthymia often occurs at an equivalent time as other psychological disorders, which adds A level of complexity in determining the presence of dysthymia, particularly because there's often an overlap in the symptoms of disorders. There is a high incidence of comorbid illness in those with dysthymia. Suicidal behaviour is also a particular problem with persons with dysthymia. It is vital to seem for signs of major depression,
anxiety disorder, generalised mental disorder, alcohol and substance misuse and mental disorder. There is some evidence of a genetic basis for all kinds of depression, including dysthymia. A study using identical and fraternal twins indicated that there's a stronger likelihood of identical twins both having depression than fraternal twins. This provides support for the idea that dysthymia is caused in part by heredity. A new
model has recently surfaced in the literature regarding the HPA axis (structures in the
brain that get activated in response to stress) and its involvement with dysthymia (e.g. phenotypic variations of corticotropin releasing
hormone (CRH) and arginine vasopressin (AVP), and down-regulation of adrenal functioning) as well as forebrain serotonergic mechanisms. Since this
model is highly provisional, further research is still needed.
High Impact List of Articles
-
Neuroprotective effects of the ergoline derivative nicergoline following transient and permanent focal cerebral ischemia in rats
Chikako Nito, Yasuhiro Nishiyama, Tomonari Saito, Satoshi Suda, Masayuki Ueda and Kazumi Kimura
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Neuroprotective effects of the ergoline derivative nicergoline following transient and permanent focal cerebral ischemia in rats
Chikako Nito, Yasuhiro Nishiyama, Tomonari Saito, Satoshi Suda, Masayuki Ueda and Kazumi Kimura
Research Article: Journal of Experimental Stroke & Translational Medicine
-
MacGreen mice: a novel tool to investigate inflammation following experimental stroke
Siyi Chen, Laura Bennet and Ailsa L. McGregor
Research Article: Journal of Experimental Stroke & Translational Medicine
-
MacGreen mice: a novel tool to investigate inflammation following experimental stroke
Siyi Chen, Laura Bennet and Ailsa L. McGregor
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Possible factors influencing postoperative temporary neurologic deterioration following standard superficial temporal artery-middle cerebral artery (STA-MCA) bypass surgery: diameter of STA and MCA (M4)
Jie Bai, Yuan-Li Zhao, Ji-Zong Zhao, Rong Wang, Dong Zhang, Song Lin and Chang-Wu Dou
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Possible factors influencing postoperative temporary neurologic deterioration following standard superficial temporal artery-middle cerebral artery (STA-MCA) bypass surgery: diameter of STA and MCA (M4)
Jie Bai, Yuan-Li Zhao, Ji-Zong Zhao, Rong Wang, Dong Zhang, Song Lin and Chang-Wu Dou
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Infection - An Amendment to the Stroke Model Guidelines
Odilo Engel, Ulrich Dirnagl and Andreas Meisel
Short Communication: Journal of Experimental Stroke & Translational Medicine
-
Infection - An Amendment to the Stroke Model Guidelines
Odilo Engel, Ulrich Dirnagl and Andreas Meisel
Short Communication: Journal of Experimental Stroke & Translational Medicine
-
Chronic treatment with Losartan and Cerebral Ischemic Tolerance
Zonghang Zhao, Ursula I. Tuor and Phil Barber
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Chronic treatment with Losartan and Cerebral Ischemic Tolerance
Zonghang Zhao, Ursula I. Tuor and Phil Barber
Research Article: Journal of Experimental Stroke & Translational Medicine
-
The Continued Promise of Neuroprotection for Acute Stroke Treatment
Shimin Liu and Steven R Levine
Review Article: Journal of Experimental Stroke & Translational Medicine
-
The Continued Promise of Neuroprotection for Acute Stroke Treatment
Shimin Liu and Steven R Levine
Review Article: Journal of Experimental Stroke & Translational Medicine
Relevant Topics in Clinical